Drastic “Reductions in Force” Upend HHS Agencies
Thousands of people who work at the Centers for Disease Control and Prevention (CDC) were notified by email today that they were subject to the Trump administration’s efforts to cull federal workforce jobs, Wired reports. Top officials were among those either put on administrative leave, laid off, or reassigned to remote roles, the Washington Post reports.
Affecting Programs and Services
HHS announced last week that it would slash its workforce by 20,000 people. Now, the nation is starting to see how that purge is rolling out, affecting programs meant to prevent and treat HIV infection and sexually transmitted disease, respiratory diseases, and foodborne illnesses, to name a few.
Criticisms and Concerns
“We’re going to have patients die, Jade Pagkas-Bather, an infectious disease doctor at the University of Chicago, tells Wired. “Unnecessary, preventable death.”
Response from HHS
“Unnecessary, preventable death.”
HHS, on the other hand, says the changes will save $1.8 billion a year. “Over time, bureaucracies like HHS become wasteful and inefficient even when most of their staff are dedicated and competent civil servants,” HHS Secretary Robert F. Kennedy, Jr. said in a press release when HHS announced its restructuring last week.
Departure of FDA Official
The FDA’s Center for Biologics Evaluation and Research (CBER) regulates vaccines, and director Peter Marks resigned on Friday, writing that “it has become clear that truth and transparency are not desired by the Secretary, but rather he wishes subservient confirmation of his misinformation and lies.”
Concerns about the FDA’s Future
“The FDA as we’ve known it is finished, with most of the leaders with institutional knowledge and a deep understanding of product development and safety no longer employed,” Robert Califf, FDA commissioner under Joe Biden and Barack Obama, wrote on LinkedIn today.
HHS Press Secretary’s Statement
In an email to The Verge, HHS press secretary Vianca Rodriguez Feliciano maintains that “ongoing critical public health efforts will remain a top priority and will not be impacted by this administrative realignment.”
Conclusion
The recent “reductions in force” at HHS agencies, including the CDC and FDA, have raised concerns about the impact on public health programs and services. Critics argue that the changes will lead to “unnecessary, preventable death,” while HHS officials claim that the changes will save $1.8 billion a year.
FAQs
Q: What is the purpose of the “reductions in force” at HHS agencies?
A: According to HHS, the changes are intended to reduce waste and inefficiency within the agencies.
Q: How will the changes affect public health programs and services?
A: The changes are likely to have a significant impact on programs meant to prevent and treat HIV infection and sexually transmitted disease, respiratory diseases, and foodborne illnesses, among others.
Q: Who is responsible for the changes at HHS agencies?
A: HHS Secretary Robert F. Kennedy, Jr. is responsible for the restructuring efforts.
Q: What is the reaction from the FDA to the changes?
A: The FDA’s Center for Biologics Evaluation and Research (CBER) regulates vaccines, and director Peter Marks resigned on Friday, criticizing the changes.
